Connect your AI

Haemonetics HAE Deferred taxes

Deferred taxes at other companies

TFX

TeleflexTFX

-$12.71M-11,669%

LivaNovaLIVN

$1.82M-18.7%

Baxter InternationalBAX

$19.25M+129%

RepligenRGEN

-$7.7M-540%

SolventumSOLV

——

Other financials

Income statement

Revenue$346.4M+4.8%

Gross profit$198.2M+2.7%

Operating income$67.4M+14.2%

Net income$44.7M+19.3%

EPS (diluted)$0.95+28.4%

Balance sheet

Cash & equivalents$245.4M-20.0%

Total debt$1.3B-0.7%

Total equity$796.3M-3.0%

Total assets$2.4B-2.2%

Cash flow

Operating cash flow$70.9M-39.1%

CapEx$17.7M+12.9%

Free cash flow$53.3M-47.2%

Valuation

Market cap$3.31B-18.0%

Profitability

Gross margin59%+4.0pp

Operating margin19%+5.9pp

Net margin13.3%+3.8pp

FCF margin19.5%+9.1pp

Returns & leverage

Return on equity19.3%+5.2pp

Debt / equity1.6×0.0×

Current ratio3×+1.3×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxExpenseBenefit.

The official record: Haemonetics’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's deferred taxes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Haemonetics's deferred taxes?: Haemonetics (HAE) reported deferred taxes of -$2.06M in Q4 2025.
How has Haemonetics's deferred taxes changed year-over-year?: Haemonetics's deferred taxes increased by 14.7% year-over-year, from -$2.42M to -$2.06M.